Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis. - Lefort, M.; Sharmin, S.; Andersen, J. B.; Vukusic, S.; Casey, R.; Debouverie, M.; Edan, G.; Ciron, J.; Ruet, A.; De Sèze, J.; Maillart, E.; Zephir, H.; et al. (BMC Medical Research Methodology, 2022)